{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:14:57Z","timestamp":1791220497992,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"the Key Research and Development Program of Sichuan Province","award":["2024YFFK0084"],"award-info":[{"award-number":["2024YFFK0084"]}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1.3.5 Project of Center for High Altitude Medicine, West China Hospital of Sichuan University"},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["GYYX24018"],"award-info":[{"award-number":["GYYX24018"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.amjms.2025.06.001","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:06:51Z","timestamp":1748948811000},"page":"285-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathogenesis and treatments for high altitude pulmonary hypertension: An updated review"],"prefix":"10.1016","volume":"370","author":[{"given":"Yuying","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjms.2025.06.001_bib0001","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/ham.2005.6.147","article-title":"Consensus statement on chronic and subacute high altitude diseases","volume":"6","author":"Le\u00f3n-Velarde","year":"2005","journal-title":"High Alt Med Biol"},{"issue":"38","key":"10.1016\/j.amjms.2025.06.001_bib0002","first-page":"3618","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.001_bib0003","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1089\/ham.2013.1112","article-title":"Prevalence of high altitude pulmonary hypertension among the natives of Spiti Valley\u2013a high altitude region in Himachal Pradesh, India","volume":"15","author":"Negi","year":"2014","journal-title":"High Alt Med Biol"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.001_bib0004","doi-asserted-by":"crossref","first-page":"1902474","DOI":"10.1183\/13993003.02474-2019","article-title":"Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250\u2005m","volume":"56","author":"Lichtblau","year":"2020","journal-title":"Eur Respir J"},{"issue":"Pt 23","key":"10.1016\/j.amjms.2025.06.001_bib0005","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1113\/jphysiol.2010.194704","article-title":"High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability","volume":"588","author":"Bailey","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.amjms.2025.06.001_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/196904","article-title":"Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks","volume":"2015","author":"Mizuno","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.amjms.2025.06.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6578578","article-title":"Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine\/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?","volume":"2016","author":"L\u00fcneburg","year":"2016","journal-title":"Pulm Med"},{"key":"10.1016\/j.amjms.2025.06.001_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1297636","article-title":"Asymmetric and symmetric dimethylarginine in high altitude pulmonary hypertension (HAPH) and high altitude pulmonary edema (HAPE)","volume":"14","author":"Hannemann","year":"2023","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.001_bib0009","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/ham.2008.1053","article-title":"Transpulmonary plasma ET-1 and nitrite differences in high altitude pulmonary hypertension","volume":"10","author":"Berger","year":"2009","journal-title":"High Alt Med Biol"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.001_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11746-998-0032-9","article-title":"Free radicals, oxidative stress, and antioxidants in human health and disease","volume":"75","author":"Aruoma","year":"1998","journal-title":"J Am Oil Chem Soc"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.001_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/152702904322963690","article-title":"Increased oxidative stress following acute and chronic high altitude exposure","volume":"5","author":"Jefferson","year":"2004","journal-title":"High Alt Med Biol"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.001_bib0012","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/ham.2019.0143","article-title":"Oxidative and Endoplasmic Reticulum Stress Responses to Chronic High-Altitude Exposure During the Development of High-Altitude Pulmonary Hypertension","volume":"21","author":"Pu","year":"2020","journal-title":"High Alt Med Biol"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.001_bib0013","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201302-0302OC","article-title":"Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1\u03b1","volume":"189","author":"Ball","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.001_bib0014","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41467-023-37527-4","article-title":"Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.001_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/ham.2005.6.133","article-title":"High altitude pulmonary hypertension: role of K+ and Ca2+ channels","volume":"6","author":"Remillard","year":"2005","journal-title":"High Alt Med Biol"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.001_bib0016","doi-asserted-by":"crossref","first-page":"L1059","DOI":"10.1152\/ajplung.00448.2004","article-title":"Acute hypoxia increases intracellular [Ca2+] in pulmonary arterial smooth muscle by enhancing capacitative Ca2+ entry","volume":"288","author":"Wang","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.001_bib0017","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/hc0202.101974","article-title":"Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels","volume":"105","author":"Michelakis","year":"2002","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.amjms.2025.06.001_bib0018","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1113\/JP272032","article-title":"AMP-activated protein kinase inhibits Kv 1.5 channel currents of pulmonary arterial myocytes in response to hypoxia and inhibition of mitochondrial oxidative phosphorylation","volume":"594","author":"Moral-Sanz","year":"2016","journal-title":"J Physiol"},{"issue":"550","key":"10.1016\/j.amjms.2025.06.001_bib0019","doi-asserted-by":"crossref","first-page":"eaau0296","DOI":"10.1126\/scisignal.aau0296","article-title":"The LKB1-AMPK-\u03b11 signaling pathway triggers hypoxic pulmonary vasoconstriction downstream of mitochondria","volume":"11","author":"Moral-Sanz","year":"2018","journal-title":"Sci Signal"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.001_bib0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s13105-020-00742-4","article-title":"AMPK\u03b12 deficiency exacerbates hypoxia-induced pulmonary hypertension by promoting pulmonary arterial smooth muscle cell proliferation","volume":"76","author":"Wang","year":"2020","journal-title":"J Physiol Biochem"},{"issue":"13","key":"10.1016\/j.amjms.2025.06.001_bib0021","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/15384101.2017.1317414","article-title":"NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer","volume":"16","author":"Karki","year":"2017","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.001_bib0022","doi-asserted-by":"crossref","first-page":"843","DOI":"10.14336\/AD.2017.1102","article-title":"NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension Diagnosis","volume":"9","author":"Zha","year":"2018","journal-title":"Aging Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113755","article-title":"NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK\/NF-\u03baB p65\/HIF-1\u03b1 pathway","volume":"431","author":"Maimaitiaili","year":"2023","journal-title":"Exp Cell Res"},{"issue":"24","key":"10.1016\/j.amjms.2025.06.001_bib0024","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.3390\/jcm10245761","article-title":"Association of Genes of the NO Pathway with Altitude Disease and Hypoxic Pulmonary Hypertension","volume":"10","author":"Hannemann","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.001_bib0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCGENETICS.114.000763","article-title":"\u03b11-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlanders","volume":"7","author":"Wilkins","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.001_bib0026","first-page":"818","article-title":"Down-Regulation of EPAS1 Transcription and Genetic Adaptation of Tibetans to High-Altitude Hypoxia","volume":"34","author":"Peng","year":"2017","journal-title":"Mol Biol Evol"},{"issue":"40","key":"10.1016\/j.amjms.2025.06.001_bib0027","first-page":"3213","article-title":"Association between genetic polymorphisms of HIF-2\u03b1 gene and high altitude pulmonary hypertension in Han population]","volume":"96","author":"Yu","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.amjms.2025.06.001_bib0028","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1038\/ncomms7863","article-title":"Increased prevalence of EPAS1 variant in cattle with high-altitude pulmonary hypertension","volume":"6","author":"Newman","year":"2015","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.amjms.2025.06.001_bib0029","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1164\/rccm.200204-345OC","article-title":"Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype","volume":"166","author":"Aldashev","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.001_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41431-018-0270-8","article-title":"Novel insight into the genetic basis of high-altitude pulmonary hypertension in Kyrgyz highlanders","volume":"27","author":"Iranmehr","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"10.1016\/j.amjms.2025.06.001_bib0031","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/hmg\/ddab291","article-title":"Heterozygous Tropomodulin 3 mice have improved lung vascularization after chronic hypoxia","volume":"31","author":"Stobdan","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.001_bib0032","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/hrt.33.5.647","article-title":"increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level","volume":"33","author":"Sime","year":"1971","journal-title":"Br Heart J"},{"issue":"7404","key":"10.1016\/j.amjms.2025.06.001_bib0033","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(65)90229-1","article-title":"HIGH-ALTITUDE PULMONARY HYPERTENSION","volume":"2","author":"Singh","year":"1965","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.amjms.2025.06.001_bib0034","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4103\/0366-6999.182831","article-title":"Intermittent Oxygen Inhalation with Proper Frequency Improves Overall Health Conditions and Alleviates Symptoms in a Population at High Risk of Chronic Mountain Sickness with Severe Symptoms","volume":"129","author":"Feng","year":"2016","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.001_bib0035","first-page":"391","article-title":"Role of oxygen therapy in prevention of chronic mountain sickness]","volume":"29","author":"Cui","year":"2013","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.001_bib0036","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/CS20231508","article-title":"Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4\/H2O2\/PPAR-\u03b3 axis","volume":"138","author":"Li","year":"2024","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.001_bib0037","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318360-000000000-00000","article-title":"Phosphodiesterase type 5 inhibitors for high-altitude pulmonary hypertension: a meta-analysis","volume":"30","author":"Jin","year":"2010","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.001_bib0038","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/ham.2022.0043","article-title":"Physiological Effects of Sildenafil Versus Placebo at High Altitude: A Systematic Review","volume":"25","author":"Poudel","year":"2024","journal-title":"High Alt Med Biol"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.001_bib0039","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/ham.2011.0011","article-title":"Sildenafil has little influence on cardiovascular hemodynamics or 6-km time trial performance in trained men and women at simulated high altitude","volume":"12","author":"Jacobs","year":"2011","journal-title":"High Alt Med Biol"},{"issue":"10","key":"10.1016\/j.amjms.2025.06.001_bib0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1055\/s-0035-1559774","article-title":"Sildenafil does not Improve Exercise Capacity under Acute Hypoxia Exposure","volume":"37","author":"Toro-Salinas","year":"2016","journal-title":"Int J Sports Med"},{"issue":"2-3","key":"10.1016\/j.amjms.2025.06.001_bib0041","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.resp.2008.10.005","article-title":"Prophylactic bosentan does not improve exercise capacity or lower pulmonary artery systolic pressure at high altitude","volume":"165","author":"Seheult","year":"2009","journal-title":"Respir Physiol Neurobiol"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.001_bib0042","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/ham.2011.1107","article-title":"Bosentan reduces pulmonary artery pressure in high altitude residents","volume":"13","author":"Kojonazarov","year":"2012","journal-title":"High Alt Med Biol"},{"issue":"8","key":"10.1016\/j.amjms.2025.06.001_bib0043","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1021\/acs.jproteome.0c00219","article-title":"Macitentan Attenuates Chronic Mountain Sickness in Rats by Regulating Arginine and Purine Metabolism","volume":"19","author":"Gao","year":"2020","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.001_bib0044","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.06.001_bib0045","article-title":"Novel Targets in a High-Altitude Pulmonary Hypertension Rat Model Based on RNA-seq and Proteomics","volume":"8","author":"Xu","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.001_bib0046","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1183\/09031936.98.12061242","article-title":"Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression","volume":"12","author":"Swenson","year":"1998","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.amjms.2025.06.001_bib0047","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200505-807OC","article-title":"Acetazolamide: a treatment for chronic mountain sickness","volume":"172","author":"Richalet","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2025.06.001_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.662870","article-title":"Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension","volume":"8","author":"Spyropoulos","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.001_bib0049","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1152\/japplphysiol.00806.2021","article-title":"Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m","volume":"132","author":"Berger","year":"2022","journal-title":"J Appl Physiol (1985)"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.001_bib0050","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00178.2006","article-title":"Role of Rho kinases in PKG-mediated relaxation of pulmonary arteries of fetal lambs exposed to chronic high altitude hypoxia","volume":"292","author":"Gao","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"10.1016\/j.amjms.2025.06.001_bib0051","doi-asserted-by":"crossref","first-page":"R1053","DOI":"10.1152\/ajpregu.00177.2015","article-title":"Role of the RhoA\/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs","volume":"310","author":"Lopez","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.001_bib0052","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.00095211","article-title":"Effects of fasudil in patients with high-altitude pulmonary hypertension","volume":"39","author":"Kojonazarov","year":"2012","journal-title":"Eur Respir J"},{"issue":"13","key":"10.1016\/j.amjms.2025.06.001_bib0053","first-page":"4540","article-title":"Research on the improvement of oxidative stress in rats with high-altitude pulmonary hypertension through the participation of irbesartan in regulating intestinal flora","volume":"25","author":"Nijiati","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.001_bib0054","first-page":"1024","article-title":"Salidroside inhibits phenotypic transformation of rat pulmonary artery smooth muscle cells induced by hypoxia","volume":"47","author":"Mao","year":"2022","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.amjms.2025.06.001_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114342","article-title":"Protection function of 18\u03b2-glycyrrhetinic acid on rats with high-altitude pulmonary hypertension based on (1)H NMR metabonomics technology","volume":"631","author":"Yang","year":"2021","journal-title":"Anal Biochem"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.001_bib0056","first-page":"533","article-title":"Effects of Salvia przewalskii Maxim. on high-altitude pulmonary hypertension in rats and its mechanism","volume":"35","author":"Wang","year":"2019","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.001_bib0057","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12906-023-03981-2","article-title":"Protective effects of the Terminalia bellirica tannin-induced Nrf2\/HO-1 signaling pathway in rats with high-altitude pulmonary hypertension","volume":"23","author":"Aimaier","year":"2023","journal-title":"BMC Complement Med Ther"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T14:34:57Z","timestamp":1755614097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925010675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0002962925010675"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.06.001","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis and treatments for high altitude pulmonary hypertension: An updated review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}